Cancer Cachexia Market: Analysis of Epidemiology, Pipeline Products, and Key Companies Working, DelveInsight | AEterna Zentaris, Aphios Corporation, Artelo BIOSCIENCES, Caelus Health, Cannabics Pharmaceuticals, Helsinn Therapeutics, Ildong Pharmaceutical,

Cancer Cachexia emerging therapies are expected to boost the Cancer Cachexia Market in the upcoming years.

DelveInsight has launched a new report on "Cancer Cachexia - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Cancer Cachexia, historical and forecasted epidemiology as well as the Cancer Cachexia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Download sample report @ https://www.delveinsight.com/report-store/cancer-cachexia-cc-market-insights?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Some of the key facts of the Cancer Cachexia Market Report:

The Cancer Cachexia Hub reports that around 50% of cancer patients experience cachexia, with this figure increasing to as high as 86% during the final 1-2 weeks of life. Additionally, 45% of these patients lose over 10% of their body weight as the disease progresses. Several secondary studies indicate that cachexia's overall incidence is high and continues to rise in developed countries, including North America, Europe, and Japan. It is currently estimated that cachexia impacts about 9 million people, roughly 1% of all patients with any disease.
A Japanese study by Aoyagi et al. titled "Cancer Cachexia, Mechanism and Treatment" states that cachexia affects the majority of terminal cancer patients and is responsible for 22% of cancer-related deaths. According to Worp et al. (2020), around 70% of gastric cancer patients, 80% of lung cancer patients, and 90% of those with liver and pancreatic cancer are at risk of developing cachexia.
It is estimated that over 30% of cancer patients die directly due to cachexia, while more than 50% of cancer patients die with cachexia present. Among patients in the later stages of cancer, cachexia affects between 50% and 80%.
According to DelveInsight, the Cancer Cachexia Market is projected to experience strong growth between 2024 and 2034, driven by the introduction of new therapies and an increase in the number of cases.
Numerous leading pharmaceutical and biotechnology companies, including AEterna Zentaris, Aphios Corporation, Artelo BIOSCIENCES, Caelus Health, Cannabics Pharmaceuticals, Helsinn Therapeutics, Ildong Pharmaceutical, Incyte Corporation, Janssen Pharmaceutical, NGM Biopharmaceuticals, Ono Pharmaceutical, PsiOxus Therapeutics, Smartfish AS, Tetra Biopharma, XBiotech, and others, are actively involved in the Cancer Cachexia Market.
Key benefits of the Cancer Cachexia market report:
Cancer Cachexia market report covers a descriptive overview and comprehensive insight of the Cancer Cachexia Epidemiology and Cancer Cachexia market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
The Cancer Cachexia market report provides insights on the current and emerging therapies.
Cancer Cachexia market report provides a global historical and forecasted market covering drug outreach in 7MM.
The Cancer Cachexia market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Cancer Cachexia market.

Got queries? Click here to know more about the Cancer Cachexia Market Landscape https://www.delveinsight.com/sample-request/cancer-cachexia-cc-market-insights?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Cancer Cachexia Overview

Cachexia is a complex metabolic disorder that affects multiple organs, characterized by at least a 5% loss in body weight, along with muscle and fat tissue wasting, and increased inflammation. When the body detects insufficient nutrition, it begins to use skeletal muscle and fat tissue as alternative energy sources. This condition is marked by an increase in pro-inflammatory factors, which greatly hinder patients' ability to fight infections and tolerate treatments such as chemotherapy and radiotherapy. Despite lower physical activity and overall energy expenditure, individuals with cachexia often have an elevated basal metabolic rate. Muscle wasting occurs due to reduced protein synthesis, heightened protein breakdown, or a combination of both, resulting in a lower quality of life and shorter survival rates.

Cancer Cachexia Market Outlook

The Cancer Cachexia market outlook in the report provides a comprehensive understanding of the historical, current, and projected trends in the Cancer Cachexia market. This is achieved by analyzing the effects of existing therapies on the market, identifying unmet needs, exploring key drivers and obstacles, and assessing the demand for improved technology.

This section offers in-depth details on the market trends for each approved drug and late-stage pipeline therapy, evaluating their influence based on factors such as the annual therapy cost, inclusion and exclusion criteria, mechanism of action, patient compliance, increasing market demand, expanding patient pool, target patient segment, expected launch dates, competition with other therapies, brand value, and input from key opinion leaders. The market data for Cancer Cachexia are presented through relevant tables and graphs, providing a clear overview of the market at a glance.

DelveInsight forecasts that the Cancer Cachexia market across the 7MM will undergo significant changes during the study period from 2020 to 2034.

To know about the cancer cachexia growing market, visit: https://www.delveinsight.com/report-store/cancer-cachexia-cc-market-insights?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Cancer Cachexia Key Companies
AEterna Zentaris, Aphios Corporation, Artelo BIOSCIENCES, Caelus Health, Cannabics Pharmaceuticals, Helsinn Therapeutics, Ildong Pharmaceutical, Incyte Corporation, Janssen Pharmaceutical, NGM Biopharmaceuticals, Ono Pharmaceutical, PsiOxus Therapeutics, Smartfish AS, Tetra Biopharma, XBiotech

Scope of the Cancer Cachexia Market Report

Study Period: 2020-2034
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
Key Cancer Cachexia Companies: AEterna Zentaris, Aphios Corporation, Artelo BIOSCIENCES, Caelus Health, Cannabics Pharmaceuticals, Helsinn Therapeutics, Ildong Pharmaceutical, Incyte Corporation, Janssen Pharmaceutical, NGM Biopharmaceuticals, Ono Pharmaceutical, PsiOxus Therapeutics, Smartfish AS, Tetra Biopharma, XBiotech, and others
Cancer Cachexia Therapeutic Assessment: Cancer Cachexia current marketed and Cancer Cachexia emerging therapies
Cancer Cachexia Market Dynamics: Cancer Cachexia market drivers and Cancer Cachexia market barriers
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
Cancer Cachexia Unmet Needs, KOL's views, Analyst's views, Cancer Cachexia Market Access and Reimbursement
To know more in detail about the cancer cachexia market report scope, visit: https://www.delveinsight.com/sample-request/cancer-cachexia-cc-market-insights?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Table of Contents

1. Report Introduction
2. Executive Summary
3. SWOT analysis
4. Cancer Cachexia Patient Share (%) Overview at a Glance
5. Cancer Cachexia Market Overview at a Glance
6. Cancer Cachexia Disease Background and Overview
7. Cancer Cachexia Epidemiology and Patient Population
8. Country-Specific Patient Population of Cancer Cachexia
9. Cancer Cachexia Current Treatment and Medical Practices
10. Unmet Needs
11. Cancer Cachexia Emerging Therapies
12. Cancer Cachexia Market Outlook
13. Country-Wise Cancer Cachexia Market Analysis (2020-2034)
14. Market Access and Reimbursement of Therapies
15. Market drivers
16. Market barriers
17. Appendix
18. Cancer Cachexia Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

Click here to read more about Cancer Cachexia Market Outlook 2034 https://www.delveinsight.com/report-store/cancer-cachexia-cc-market-insights?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Related Reports:

Cancer Cachexia Pipeline Insights, DelveInsight

"Cancer Cachexia Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Cancer Cachexia market. A detailed picture of the Cancer Cachexia pipeline landscape is provided, which includes the disease overview and Cancer Cachexia treatment guidelines.

Contact Info:

Kritika Rehani, Team Leader Marketing & Branding
krehani@delveinsight.com
info@delveinsight.com
www.delveinsight.com
+14699457679

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

This release was published on openPR.